...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith trial partners
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hey Fuzzy, here's something else for you.  Give the 7-day trial a go.  Get the raging voices out of your head.  It can't be much fun for you.  Or anyone else around you.  Best of luck.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply